Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Arch. med. res ; 28(4): 527-30, dec. 1997. tab, ilus
Article in English | LILACS | ID: lil-225258

ABSTRACT

Toxoplasmosis of the central nervous system (CNS) is the most common cause of intracerebral lesions in patients with AIDS. It is now standard clinical practice to treat empirically, based on clinical and radiographic findings, and to perform a biopsy of the lesion only in those patients who fail to have a clinical and radiographic response after two weeks of therapy. This study describes the presentation and response to therapy of central nervous system toxoplasmosis in patients with AIDS at a private practice in Mexico City. A retrospective chart an radiology view of all patients with AIDS treated empirically for toxoplasmosis between 1988 and 1993 was performed. A total of 177 patients with AIDS were seen, nine (5.1 percent) had toxoplasmosis. Patients with toxoplasmosis were males with a median age of 39 years (range - 65). In two patients, toxoplasmosis of the CNS was the initial manifestation of HIV infection, all others had a prior diagnosis of AIDS with a mean of 10 months between their first AIDS defining event and the diagnosis of toxoplasmosis. The median CD+T-cell count at the time of the diagnosis of toxoplasmosis was 78 cells/µL. Most patients had headache associate with other focal neurological symptoms such as hemiplegia (2), hemiparesis (2) or seizures (4). Only 4 out of 9 patients had fever as part of their initial clinical presentation. Serum IgG antibodies against Toxoplasma gondii were positive in 6 out of 7 patients tested, while IgM antibodies were negative in all patients. On imaging studies (Computerized Tomography or Magnetic Resonance Imaging), 4 patients had a single lesion while the rest had two or more lesions. Two patients were initially treated with pyrimethamine/sulfadiazine and were later changed to pryrimethamine/clindamycin, which was the treatment given from the beginning to all other patients. One patient died of an intralesional hemorrhage two weeks after the diagnosis despite adequate therapy. The probability of surviving 6 months after the diagnosis of toxoplasmosis was 60 percent. The findings of these authors are similar to those reported in other series where toxoplasmosis of the CNS is a late complication of HIV infection associated with a CD4+ cell count of < 100 cells/µL. However, survival was short in spite of good response to therapy


Subject(s)
Humans , Adult , Middle Aged , AIDS-Related Opportunistic Infections/parasitology , AIDS-Related Opportunistic Infections/pathology , Magnetic Resonance Imaging , Acquired Immunodeficiency Syndrome/parasitology , Acquired Immunodeficiency Syndrome/pathology , Tomography, X-Ray Computed , Toxoplasmosis, Cerebral/etiology , Toxoplasmosis, Cerebral/pathology
2.
Arch. med. res ; 27(2): 201-4, 1996. tab, ilus
Article in English | LILACS | ID: lil-200315

ABSTRACT

The objective of this study was to describe the epidemiology and clinical presentation of HIV infection among upper middle class patients in Mexico City. A retrospective review of outpatient and hospital records of all HIV-infected patients was accomplished by one of the authors between 1984 and 1990. A total of 115 patients were seen during the study period, 109 men and women. One hundred and seven patients acquired HIV infection through sexual contact, six patients had HIV infection associated with blood transfusion and two were homosexual men who also had a history of intravenous drug use. The mean age of the patients was 36.2 years (range 13 - 65 years). CDC classification at presentation was predominantly stage IV (65 per cent) with the most common AIDS associated diseases at presentation being wasting syndrome in 30 (42.2 per cent, P. carinii peneumonia in 22 (30.9 per cent), cytomegalovirus infection in 11 (15.5 per cent), Cryptosporidium parvum diarrhea in 7 (9.8 per cent), and Kaposi's sarcoma in 6 (8.4 per cent). CD4+ T-lymphocyte cell counts at the time of HIV diagnosis were available in 87 patients (median = 150 cells/µl, SD ñ 219). Zidovudine was used in 37 patients after 1988 when it first became available in Mexico, in six patients the drug had to bedicontinued because of serious hematologic toxicity. The average follow-up on zidovudine was 8.5 months. Similar age, gender, age distribution, risk categories and CDC classification at presentation was seen compared to other series reported from Mexico. However, the spectrum of opportunistic infections found were similar to that seen in the United States


Subject(s)
Adolescent , Adult , Middle Aged , Humans , Male , Female , AIDS-Related Opportunistic Infections/physiopathology , HIV Infections/physiopathology , Risk Factors , AIDS Serodiagnosis/methods , Acquired Immunodeficiency Syndrome/epidemiology , Substance-Related Disorders
SELECTION OF CITATIONS
SEARCH DETAIL